Cargando…
A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development
Autores principales: | Madabushi, Rajanikanth, Wang, Yaning, Zineh, Issam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363064/ https://www.ncbi.nlm.nih.gov/pubmed/30582301 http://dx.doi.org/10.1002/psp4.12379 |
Ejemplares similares
-
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs
por: Schuck, Robert N., et al.
Publicado: (2019) -
Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Jean, Daphney, et al.
Publicado: (2021) -
Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
por: Madabushi, Rajanikanth, et al.
Publicado: (2022) -
Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
por: Zineh, Issam
Publicado: (2019) -
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
por: Shord, Stacy S., et al.
Publicado: (2023)